Events Archives - Page 39 of 128

1 minute read

Onconova Therapeutics Announces Rigosertib Data Presented At EADV As Late Breaker

October 12, 8:09 AM

Onconova Therapeutics, Inc. (NASDAQ:ONTX), ("Onconova", the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that a

ONTX

2 minute read

Short Seller Carson Block Teases New Short Idea, Reflects On Successful 43% YTD Drop Bet

By Adam Eckert

October 11, 1:43 PM

Muddy Waters Research founder Carson Block teased a new short idea ahead of Robin Hood’s Annual Investors conference later this month and touched on a previous target that worked out pretty well for the activist short seller.

HASI

1 minute read

PMV Pharmaceuticals To Present Updated Phase 1 Data On PC14586 At The 2023 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics And Host A KOL Webinar

By Benzinga Newsdesk

October 11, 12:05 PM

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that it will present updated

PMVP

3 minute read

Valneva To Present On Chikungunya At Several Leading Scientific Conferences

By Benzinga Newsdesk

October 11, 11:46 AM

Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, announces today it will present on the mosquito-borne chikungunya disease at several leading scientific conferences during the fourth quarter of 2023.At

PARIS:VLA

3 minute read

TG Therapeutics Announces Presentation Of Data For BRIUMVI At The 2023 European Committee For Treatment And Research In Multiple Sclerosis Annual Meeting

By Benzinga Newsdesk

October 11, 10:31 AM

TG Therapeutics, Inc. (NASDAQ:TGTX) today announced the presentation of data from both the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b trial evaluating BRIUMVI® (ublituximab-xiiy) in patients

TGTX

4 minute read

MoonLake Immunotherapeutics Presents 12-Week Data From The Phase 2 Mira Trial With Nanobody Sonelokimab For Hidradenitis Suppurativa At The European Academy Of Dermatology And Venereology Congress

By Benzinga Newsdesk

October 11, 10:17 AM

MoonLake Immunotherapeutics presents positive 12-week data from thePhase 2 MIRA trial with Nanobody® Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology CongressPeer

MLTX

4 minute read

BriaCell To Host Virtual Key Opinion Leader Event On Bria-IMT Potential In Advanced Metastatic Breast Cancer On October 26, 2023 Featuring Dr. Adam M. Brufsky From University Of Pittsburgh School Of Medicine And Dr. Saranya Chumsri From Mayo Clinic

By Benzinga Newsdesk

October 11, 9:11 AM

Dr. Adam M. Brufsky of University of Pittsburgh School of Medicine and Dr. Saranya Chumsri of Mayo Clinic will discuss the current treatment landscape for patients with advanced metastatic breast cancer and the latest

BCTX

1 minute read

What’s Going On With Plug Power Stock?

By Adam Eckert

October 11, 9:04 AM

Plug Power Inc (NASDAQ: PLUG) shares are trading higher. The company on Wednesday disclosed new information in a regulatory filing ahead of its annual symposium.

PLUG

3 minute read

Relmada Therapeutics To Present New Preclinical Data On Its Psilocybin Program At AASLD The Liver Meeting 2023

By Benzinga Newsdesk

October 11, 8:41 AM

Low-dose psilocybin generated statistically significant reductions in liver fat content, plasma glucose levels and body weight gain in a mice model with high-fat-high-fructose diet (HFHFD)-induced metabolic

RLMD

2 minute read

Novavax Advances Science Supporting Protein-Based Vaccine Technology At IDWeek 2023 and World Vaccine Congress Europe 2023

By Benzinga Newsdesk

October 11, 8:03 AM

Novavax, Inc. (NASDAQ:NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, will present study findings during two posters sessions at IDWeek 2023, October 11-15, and three oral

NVAX